Synaptic Vesicular Amine Transporter (SLC18A2) Peptide
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Synaptic Vesicular Amine Transporter (SLC18A2) Peptide is a synthetic peptide.
Documents del producto
Product specifications
| Category | Proteins and Peptides |
| Immunogen Target | Synaptic Vesicular Amine Transporter (SLC18A2) |
| Host | Synthetic |
| Recommended Dilution | BL (predicted): 0.5 mg/ml. Optimal dilutions/concentrations should be determined by the end user. |
| Conjugation | Unconjugated |
| Observed MW | Sequence Fragment: C-Terminus: C-SYPIGEDEESESD |
| Size 1 | 100 µg |
| Form | Lyophilized Reconstitute in deionized water. |
| Tested Applications | P-ELISA |
| Buffer | Prior to lyophilization: Deionized water. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Gene ID | 6571, 214084, 25549 |
| NCBI Accession | NP_003045.2 |
| Background | Protein SLC18A2 |
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
Related Products
SLC18A2 antibody
VMAT2 is a vesicular monoamine transporter that is responsible for the uptake and storage of monoamines(dopaine, norepinephrine, epinephrine, histamine and serotonin) in neurons, endocrine cells, and tumors deriving from these cells. Histamine-producing endocrine tumors(gastric carcinoids) expressed VMAT2 almost exclusively, thus VMAT2 is useful in classification of neuroendocrine tumors. Reduced expression of VMAT2 has often been observed in Parkinson’s diseased(PD) brain, and detection of VMAT2 can be used to reflect the dopamine neuron loss and predict the disease process. VMAT2 migrated as a major band of 65-75 kDa and a minor band of 55-60 kDa, representing the glycosylated form and native form.
Ver Producto
Solute Carrier Family 18,Member 2 (SLC18A2) Antibody
SLC18A2 Antibody is a Rabbit Polyclonal antibody against SLC18A2. The vesicular monoamine transporter acts to accumulate cytosolic monoamines into synaptic vesicles, using the proton gradient maintained across the synaptic vesicular membrane. Its proper function is essential to the correct activity of the monoaminergic systems that have been implicated in several human neuropsychiatric disorders. The transporter is a site of action of important drugs, including reserpine and tetrabenazine.
Ver Producto
Solute Carrier Family 18,Member 2 (SLC18A2) Antibody
Solute Carrier Family 18 (Vesicular Monoamine), Member 2 Antibody is a Rabbit Polyclonal antibody against Solute Carrier Family 18 (Vesicular Monoamine), Member 2.
Ver Producto